Analysis of the Disulfide Bond Arrangement of the HIV-1 Envelope Protein CON-S gp140 ΔCFI Shows Variability in the V1 and V2 Regions

被引:37
|
作者
Go, Eden P. [1 ]
Zhang, Ying [1 ]
Menon, Sushma [1 ]
Desaire, Heather [1 ]
机构
[1] Univ Kansas, Dept Chem, Lawrence, KS 66047 USA
基金
美国国家卫生研究院;
关键词
disulfide; mass spectrometry; HIV-1; envelope protein; LC/ESI-FTICR; HUMAN-IMMUNODEFICIENCY-VIRUS; RECOMBINANT GLYCOPROTEIN-120 VACCINE; N-GLYCOSYLATION SITES; MASS-SPECTROMETRY; SUBTYPE-B; EXTRACELLULAR DOMAIN; SERUM-ALBUMIN; TYPE-1; GP120; ANTIBODIES; INFECTION;
D O I
10.1021/pr100764a
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Disulfide bonding of cysteines is one of the most important protein modifications, and it plays a key role in establishing/maintaining protein structures in biologically active forms. Therefore, the determination of disulfide bond arrangement is one important aspect to understanding the chemical structure of a protein and defining its functional domains. Herein, aiming to understand how the HIV-1 envelope protein's structure influences its immunogenicity, we used an MS-based approach, liquid chromatography electrospray ionization Fourier transform ion cyclotron resonance (LC/ESI-FTICR) mass spectrometry, to determine the disulfide linkages on an oligomeric form of the group M consensus HIV-1 envelope protein (Env), CON-S gp140 Delta CFI. This protein has marked improvement in its immunogenicity compared to monomeric gp120 and wild-type forms of gp140 Envs. Our results demonstrate that the disulfide connectivity in the N-terminal region of CON-S gp140 Delta CFI is different from the disulfide bonding previously reported in the monomeric form of gp120 HIV-1 Env. Additionally, heterogeneity of the disulfide bonding was detected in this region. These data suggest that the V1/V2 region does not have a single, conserved disulfide bonding pattern and that variability could impact immunogenicity of expressed Envs.
引用
收藏
页码:578 / 591
页数:14
相关论文
共 49 条
  • [41] Induction of linear and conformational V2-specific antibodies using HIV-1 gp145 clade B envelope protein as the immunogen
    Rao, Mangala
    Peachman, Kristina
    Jobe, Ousman
    Kuaban, Alice
    Billings, Erik
    Guao, Guofen
    Wieczorek, Lindsay
    Polonis, Victoria
    Pinter, Abraham
    Kim, Jerome
    Michael, Nelson
    Alving, Carl
    Rao, Venigalla
    JOURNAL OF IMMUNOLOGY, 2013, 190
  • [42] Glycosylation and Disulfide Bond Analysis of Transiently and Stably Expressed Clade C HIV-1 gp140 Trimers in 293T Cells Identifies Disulfide Heterogeneity Present in Both Proteins and Differences in O-Linked Glycosylation
    Go, Eden P.
    Hua, David
    Desaire, Heather
    JOURNAL OF PROTEOME RESEARCH, 2014, 13 (09) : 4012 - 4027
  • [43] Deep Sequencing of the HIV-1 env Gene Reveals Discrete X4 Lineages and Linkage Disequilibrium between X4 and R5 Viruses in the V1/V2 and V3 Variable Regions
    Zhou, Shuntai
    Bednar, Maria M.
    Sturdevant, Christa B.
    Hauser, Blake M.
    Swanstrom, Ronald
    JOURNAL OF VIROLOGY, 2016, 90 (16) : 7142 - 7158
  • [44] Plasma IgG to Linear Epitopes in the V2 and V3 Regions of HIV-1 gp120 Correlate with a Reduced Risk of Infection in the RV144 Vaccine Efficacy Trial
    Gottardo, Raphael
    Bailer, Robert T.
    Korber, Bette T.
    Gnanakaran, S.
    Phillips, Joshua
    Shen, Xiaoying
    Tomaras, Georgia D.
    Turk, Ellen
    Imholte, Gregory
    Eckler, Larry
    Wenschuh, Holger
    Zerweck, Johannes
    Greene, Kelli
    Gao, Hongmei
    Berman, Phillip W.
    Francis, Donald
    Sinangil, Faruk
    Lee, Carter
    Nitayaphan, Sorachai
    Rerks-Ngarm, Supachai
    Kaewkungwal, Jaranit
    Pitisuttithum, Punnee
    Tartaglia, James
    Robb, Merlin L.
    Michael, Nelson L.
    Kim, Jerome H.
    Zolla-Pazner, Susan
    Haynes, Barton F.
    Mascola, John R.
    Self, Steve
    Gilbert, Peter
    Montefiori, David C.
    PLOS ONE, 2013, 8 (09):
  • [45] Thymic pathogenicity of an HIV-1 envelope is associated with increased CXCR4 binding efficiency and V5-gp41-dependent activity, but not V1/N2-associated CD4 binding efficiency and viral entry
    Meissner, EG
    Coffield, VM
    Su, LS
    VIROLOGY, 2005, 336 (02) : 184 - 197
  • [46] Developability Assessment of Physicochemical Properties and Stability Profiles of HIV-1 BG505 SOSIP.664 and BG505 SOSIP.v4.1-GT1.1 gp140 Envelope Glycoprotein Trimers as Candidate Vaccine Antigens
    Whitaker, Neal
    Hickey, John M.
    Kaur, Kawaljit
    Xiong, Jian
    Sawant, Nishant
    Cupo, Albert
    Lee, Wen-Hsin
    Ozorowski, Gabriel
    Medina-Ramirez, Max
    Ward, Andrew B.
    Sanders, Rogier W.
    Moore, John P.
    Joshi, Sangeeta B.
    Volkin, David B.
    Dey, Antu K.
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2019, 108 (07) : 2264 - 2277
  • [47] Structural analysis of the unmutated ancestor of the HIV-1 envelope V2 region antibody CH58 isolated from an RV144 vaccine efficacy trial vaccinee
    Nicely, Nathan I.
    Wiehe, Kevin
    Kepler, Thomas B.
    Jaeger, Frederick H.
    Dennison, S. Moses
    Rerks-Ngarm, Supachai
    Nitayaphan, Sorachai
    Pitisuttithum, Punnee
    Kaewkungwal, Jaranit
    Robb, Merlin L.
    O'Connell, Robert J.
    Michael, Nelson L.
    Kim, Jerome H.
    Liao, Hua-Xin
    Alam, S. Munir
    Hwang, Kwan-Ki
    Bonsignori, Mattia
    Haynes, Barton F.
    EBIOMEDICINE, 2015, 2 (07): : 713 - 722
  • [48] TRYPTASE-TL2 IN THE MEMBRANE OF HUMAN LYMPHOCYTES-T4+ IS A NOVEL BINDING-PROTEIN OF THE V3 DOMAIN OF HIV-1 ENVELOPE GLYCOPROTEIN-GP120
    KIDO, H
    FUKUTOMI, A
    KATUNUMA, N
    FEBS LETTERS, 1991, 286 (1-2) : 233 - 236
  • [49] Human Immunodeficiency Virus C.1086 Envelope gp140 Protein Boosts following DNA/Modified Vaccinia Virus Ankara Vaccination Fail To Enhance Heterologous Anti-V1V2 Antibody Response and Protection against Clade C Simian-Human Immunodeficiency Virus Challenge
    Styles, Tiffany M.
    Gangadhara, Sailaja
    Reddy, Pradeep B. J.
    Hicks, Sakeenah
    LaBranche, Celia C.
    Montefiori, David C.
    Derdeyn, Cynthia A.
    Kozlowski, Pamela A.
    Velu, Vijayakumar
    Amara, Rama Rao
    JOURNAL OF VIROLOGY, 2019, 93 (20)